SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-107458
Filing Date
2024-09-17
Accepted
2024-09-17 18:20:32
Documents
1
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12651
  Complete submission text file 0000950170-24-107458.txt   14109
Mailing Address C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801
Business Address
Esposito Pamela (Reporting) CIK: 0001744425 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 241305662

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)